Cargando…

Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy

OBJECTIVES: To characterise pregnancy course and outcomes in women with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). METHODS: From a combined Johns Hopkins/Dutch ARVD/C registry, we identified 26 women affected with ARVD/C (by 2010 Task Force Criteria) during 39 singleton preg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hodes, Anke R, Tichnell, Crystal, te Riele, Anneline S J M, Murray, Brittney, Groeneweg, Judith A, Sawant, Abhishek C, Russell, Stuart D, van Spaendonck-Zwarts, Karin Y, van den Berg, Maarten P, Wilde, Arthur A, Tandri, Harikrishna, Judge, Daniel P, Hauer, Richard N W, Calkins, Hugh, van Tintelen, J Peter, James, Cynthia A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Special Populations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752646/ https://www.ncbi.nlm.nih.gov/pubmed/26719359 http://dx.doi.org/10.1136/heartjnl-2015-308624

Ejemplares similares

Exercise has a Disproportionate Role in the Pathogenesis of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in Patients Without Desmosomal Mutations
por: Sawant, Abhishek C., et al.
Publicado: (2014)

Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)
por: Murray, Brittney, et al.
Publicado: (2018)

Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications
por: Orgeron, Gabriela M., et al.
Publicado: (2017)

Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update
por: te Riele, Anneline SJM, et al.
Publicado: (2014)

Left ventricular fibro-fatty replacement in arrhythmogenic right ventricular dysplasia/cardiomyopathy: prevalence, patterns, and association with arrhythmias
por: Zghaib, Tarek, et al.
Publicado: (2021)

Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 Task Force Criteria: clinical performance and simplified practical implementation
por: Bosman, Laurens P, et al.
Publicado: (2020)

Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy
por: Bosman, Laurens P, et al.
Publicado: (2021)

Feature tracking CMR reveals abnormal strain in preclinical arrhythmogenic right ventricular dysplasia/ cardiomyopathy: a multisoftware feasibility and clinical implementation study
por: Bourfiss, Mimount, et al.
Publicado: (2017)

Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
por: Wang, Weijia, et al.
Publicado: (2018)

Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
por: Scheel, Paul J., et al.
Publicado: (2020)

Right Ventricular Strain Predicts Structural Disease Progression in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
por: Malik, Nitin, et al.
Publicado: (2020)

Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
por: Gasperetti, Alessio, et al.
Publicado: (2023)

Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience
por: Orgeron, Gabriela M., et al.
Publicado: (2018)

Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration
por: Cadrin-Tourigny, Julia, et al.
Publicado: (2020)

Arrhythmogenic Right Ventricular Cardiomyopathy in Pediatric Patients: An Important but Underrecognized Clinical Entity
por: te Riele, Anneline S. J. M., et al.
Publicado: (2021)

Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study
por: Gasperetti, Alessio, et al.
Publicado: (2022)

A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy( )
por: Cadrin-Tourigny, Julia, et al.
Publicado: (2022)

Arrhythmogenic cardiomyopathy: diagnosis, genetic background, and risk management
por: Groeneweg, J. A., et al.
Publicado: (2014)

Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia
por: Jain, Aditya, et al.
Publicado: (2008)

Retracted and Republished: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy
por: Cadrin-Tourigny, Julia, et al.
Publicado: (2019)

Arrhythmogenic cardiomyopathy: pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy
por: van der Voorn, Stephanie M, et al.
Publicado: (2020)

Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience
por: Scheel, Paul J., et al.
Publicado: (2021)

Quantitative Approach to Fragmented QRS in Arrhythmogenic Cardiomyopathy: From Disease towards Asymptomatic Carriers of Pathogenic Variants
por: Roudijk, Rob W., et al.
Publicado: (2020)

Late evolution of arrhythmogenic cardiomyopathy in patients with initial presentation as idiopathic ventricular fibrillation
por: Blom, Lennart J., et al.
Publicado: (2018)

The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update
por: Bosman, L. P., et al.
Publicado: (2019)

Clinical characteristics and risk stratification of desmoplakin cardiomyopathy
por: Wang, Weijia, et al.
Publicado: (2021)

Prognostic value of strain by feature-tracking cardiac magnetic resonance in arrhythmogenic right ventricular cardiomyopathy
por: Bourfiss, M, et al.
Publicado: (2022)

No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy
por: Hoorntje, Edgar T., et al.
Publicado: (2018)

Circulating Biomarkers of Fibrosis Formation in Patients with Arrhythmogenic Cardiomyopathy
por: van der Voorn, Stephanie M., et al.
Publicado: (2023)

Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy
por: van der Zwaag, P. A., et al.
Publicado: (2013)

Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis
por: Corrado, Domenico, et al.
Publicado: (2020)

Impact of new electrocardiographic criteria in arrhythmogenic cardiomyopathy
por: Hauer, Richard N. W., et al.
Publicado: (2012)

Predicting ventricular tachycardia circuits in patients with arrhythmogenic right ventricular cardiomyopathy using genotype-specific heart digital twins
por: Zhang, Yingnan, et al.
Publicado: (2023)

The arrhythmogenic cardiomyopathy phenotype associated with PKP2 c.1211dup variant
por: Bos, Thomas A., et al.
Publicado: (2023)

Predicting Ventricular Tachycardia Circuits in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy using Genotype-specific Heart Digital Twins
por: Zhang, Yingnan, et al.
Publicado: (2023)

Arrhythmogenic Right Ventricular Cardiomyopathy in a Pediatric Patient
por: Roudijk, Rob W., et al.
Publicado: (2020)

Dual-Organ Transplantation in a Woman With Right Ventricular Failure Secondary to Arrhythmogenic Right Ventricular Cardiomyopathy
por: Lewsey, Sabra C., et al.
Publicado: (2020)

Psychosocial Stress Hastens Disease Progression and Sudden Death in Mice with Arrhythmogenic Cardiomyopathy
por: Agrimi, Jacopo, et al.
Publicado: (2020)

Clinical characterisation and risk stratification of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy ≥50 years of age
por: van der Pols, M. J., et al.
Publicado: (2016)

Surgical correction of tricuspid regurgitation in patients with ARVD/C
por: Katritsis, George, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jm6r5fptjn0kr561bdim8g7qe3